B. Larson

Genetics · Cell Stem Cell · 2002–2009

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom B. Larson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Caplan

Who trusts B. Larson overall

  1. Andrea Augello

Papers from B. Larson's perspective

Ordered by how strongly the researchers B. Larson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) (Bone Marrow Transplantation)
  2. Why are MSCs therapeutic? New data: new insight (Journal of Pathology)
  3. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. (Blood)
  4. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. (Cytotherapy)
  5. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells (Journal of Cellular Physiology)
  6. The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion (Cells Tissues Organs)
  7. Paracrine mechanisms in adult stem cell signaling and therapy (Circulation Research)
  8. Pyroptosis: host cell death and inflammation (Nature Reviews Microbiology)
  9. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis (Nature Medicine)
  10. Resolvin E1 and protectin D1 activate inflammation-resolution programmes (Nature)

Their papers